We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
You may need to tell DVLA if you have lung cancer - download the correct form if you need to let them know
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Information on the programme, including commissioning, quality assurance, education and training.
This guidance explains what the Sloane Project is and how breast screening units (BSUs) can submit data.
Guidance and advice from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
You may need to tell DVLA if you have malignant melanoma - download the correct form if you need to let them know
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Lead and co-ordinate PHE’s cancer-related work to support the Independent Cancer Taskforce recommendations to prevent and beat cancer.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Information on the NHS Cervical Screening Programme, including commissioning, quality assurance, education and training.
Quarterly updates to the emergency presentations of cancer data by Public Health England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.